Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: A meta-analysis

J Med Virol. 2021 Feb;93(2):695-697. doi: 10.1002/jmv.26498. Epub 2020 Sep 30.

Authors

Chia Siang Kow¹, Syed Shahzad Hasan^{2

3}

Affiliations

¹ School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia.
² Department of Pharmacy, University of Huddersfield, Huddersfield, UK.
³ School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia.

PMID: 32902868
DOI: 10.1002/jmv.26498

No abstract available

Publication types

Letter
Meta-Analysis

MeSH terms

COVID-19 / mortality*
Cohort Studies
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy*
Diabetes Mellitus, Type 2 / virology*
Humans
Metformin / adverse effects*
Observational Studies as Topic
Risk Assessment

Substances

Metformin